Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations

October 2, 2025

View Press Release Corporate presentation Contact us
Previous